Disturbance of cardiac gene expression and cardiomyocyte structure predisposes Mecp2-null mice to arrhythmias

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Hara, Munetsugu ^a,c   Takahashi, Tomoyuki ^a,c   Mitsumasu, Chiaki ^a,c   Igata, Sachiyo ^c   Takano, Makoto ^c   Minami, Tomoko ^b   Yasukawa, Hideo ^b   Okayama, Satoko ^c   Nakamura, Keiichiro ^c   Okabe, Yasunori ^a,c   Tanaka, Eiichiro ^c   Takemura, Genzou ^d   Kosai, Ken Ichiro ^a,c,e   Yamashita, Yushiro ^c   Matsuishi, Toyojiro ^a,c  

^a Cognitive and Molecular Research Institute of Brain Diseases   (Japan)

^b KURUME UNIVERSITY   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d ASAHI UNIVERSITY   (Japan)

^e KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MECP2 PROTEIN, MOUSE; METHYL CPG BINDING PROTEIN 2; MYOSIN; T BOX TRANSCRIPTION FACTOR; T-BOX TRANSCRIPTION FACTOR 5;

ANIMAL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CELL DIFFERENTIATION; CPG ISLAND; DEFICIENCY; DISEASE MODEL; DNA METHYLATION; EMBRYONIC STEM CELL; FEMALE; GENE EXPRESSION PROFILING; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; HEART ARRHYTHMIA; HUMAN; KNOCKOUT MOUSE; METABOLISM; MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ARRHYTHMIAS, CARDIAC; CELL DIFFERENTIATION; CPG ISLANDS; DISEASE MODELS, ANIMAL; DNA METHYLATION; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, KNOCKOUT; MYOCARDIUM; MYOCYTES, CARDIAC; MYOSINS; SIGNAL TRANSDUCTION; T-BOX DOMAIN PROTEINS;

EID: 84935923070     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11204     Document Type: Article

References (56)

1. Bienvenu, T. & Chelly, J. Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Nat Rev Genet 7, 415-26 (2006).
2. Chahrour, M. & Zoghbi, H. Y. The story of Rett syndrome: from clinic to neurobiology. Neuron 56, 422-37 (2007).
3. Guy, J., Cheval, H., Selfridge, J. & Bird, A. The role of MeCP2 in the brain. Annu Rev Cell Dev Biol 27, 631-52 (2011).
4. Amir, R. E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23, 185-8 (1999).
5. Shahbazian, M. D., Antalffy, B., Armstrong, D. L. & Zoghbi, H. Y. Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 11, 115-24 (2002).
6. Glaze, D. G. Neurophysiology of Rett syndrome. J Child Neurol 20, 740-6 (2005).
7. Matsuishi, T., Yamashita, Y., Takahashi, T. & Nagamitsu, S. Rett syndrome: the state of clinical and basic research, and future perspectives. Brain Dev 33, 627-31 (2011).
8. Chen, R. Z., Akbarian, S., Tudor, M. & Jaenisch, R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27, 327-31 (2001).
9. Guy, J., Hendrich, B., Holmes, M., Martin, J. E. & Bird, A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27, 322-6 (2001).
10. Sekul, E. A. et al. Electrocardiographic findings in Rett syndrome: an explanation for sudden death? J Pediatr 125, 80-2 (1994).
11. Kerr, A. M., Armstrong, D. D., Prescott, R. J., Doyle, D. & Kearney, D. L. Rett syndrome: analysis of deaths in the British survey. Eur Child Adolesc Psychiatry 6 Suppl 1, 71-4 (1997).
12. Acampa, M. & Guideri, F. Cardiac disease and Rett syndrome. Arch Dis Child 91, 440-3 (2006).
13. Laurvick, C. L. et al. Rett syndrome in Australia: a review of the epidemiology. J Pediatr 148, 347-52 (2006).
14. Julu, P. O., Kerr, A. M., Hansen, S., Apartopoulos, F. & Jamal, G. A. Immaturity of medullary cardiorespiratory neurones leading to inappropriate autonomic reactions as a likely cause of sudden death in Rett's syndrome. Arch Dis Child 77, 464-5 (1997).
15. Weese-Mayer, D. E. et al. Autonomic nervous system dysregulation: breathing and heart rate perturbation during wakefulness in young girls with Rett syndrome. Pediatr Res 60, 443-9 (2006).
16. Bissonnette, J. M., Knopp, S. J., Maylie, J. & Thong, T. Autonomic cardiovascular control in methyl-CpG-binding protein 2 (Mecp2) deficient mice. Auton Neurosci 136, 82-9 (2007).
17. McCauley, M. D. et al. Pathogenesis of lethal cardiac arrhythmias in Mecp2 mutant mice: implication for therapy in Rett syndrome. Sci Transl Med 3, 113ra125 (2011).
18. De Felice, C. et al. Subclinical myocardial dysfunction in Rett syndrome. Eur Heart J Cardiovasc Imaging 13, 339-45 (2012).
19. Alvarez-Saavedra, M. et al. Elevated expression of MeCP2 in cardiac and skeletal tissues is detrimental for normal development. Hum Mol Genet 19, 2177-90 (2010).
20. Kou, C. Y. et al. Epigenetic regulation of neonatal cardiomyocytes differentiation. Biochem Biophys Res Commun 400, 278-83 (2010).
21. Yamashita, J. K. et al. Prospective identification of cardiac progenitors by a novel single cell-based cardiomyocyte induction. FASEB J 19, 1534-6 (2005).
22. Kattman, S. J., Huber, T. L. & Keller, G. M. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell 11, 723-32 (2006).
23. Bondue, A. et al. Defining the earliest step of cardiovascular progenitor specification during embryonic stem cell differentiation. J Cell Biol 192, 751-65 (2011).
24. Saga, Y., Kitajima, S. & Miyagawa-Tomita, S. Mesp1 expression is the earliest sign of cardiovascular development. Trends Cardiovasc Med 10, 345-52 (2000).
25. Bondue, A. & Blanpain, C. Mesp1: a key regulator of cardiovascular lineage commitment. Circ Res 107, 1414-27 (2010).
26. Severs, N. J., Bruce, A. F., Dupont, E. & Rothery, S. Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res 80, 9-19 (2008).
27. Ferrans, V. J., Jones, M., Maron, B. J. & Roberts, W. C. The nuclear membranes in hypertrophied human cardiac muscle cells. Am J Pathol 78, 427-60 (1975).
28. Terman, A. & Brunk, U. T. Autophagy in cardiac myocyte homeostasis, aging, and pathology. Cardiovasc Res 68, 355-65 (2005).
29. Kanamori, H. et al. Functional significance and morphological characterization of starvation-induced autophagy in the adult heart. Am J Pathol 174, 1705-14 (2009).
30. Guerrero, P. A. et al. Slow ventricular conduction in mice heterozygous for a connexin43 null mutation. J Clin Invest 99, 1991-8 (1997).
31. Gutstein, D. E. et al. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res 88, 333-9 (2001).
32. Morley, G. E. et al. Characterization of conduction in the ventricles of normal and heterozygous Cx43 knockout mice using optical mapping. J Cardiovasc Electrophysiol 10, 1361-75 (1999).
33. Lo, C. W. Role of gap junctions in cardiac conduction and development: insights from the connexin knockout mice. Circ Res 87, 346-8 (2000).
34. Lerner, D. L., Yamada, K. A., Schuessler, R. B. & Saffitz, J. E. Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in Cx43-deficient mice. Circulation 101, 547-52 (2000).
35. Ward, C. S. et al. MeCP2 is critical within HoxB1-derived tissues of mice for normal lifespan. J Neurosci 31, 10359-70 (2011).
36. Arad, M. et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest 109, 357-62 (2002).
37. Arad, M. et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 352, 362-72 (2005).
38. Mah, C. et al. Physiological correction of Pompe disease by systemic delivery of adeno-associated virus serotype 1 vectors. Mol Ther 15, 501-7 (2007).
39. Haberland, M., Montgomery, R. L. & Olson, E. N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 10, 32-42 (2009).
40. Handy, D. E., Castro, R. & Loscalzo, J. Epigenetic modifications: basic mechanisms and role in cardiovascular disease. Circulation 123, 2145-56 (2011).
41. Chang, C. P. & Bruneau, B. G. Epigenetics and cardiovascular development. Annu Rev Physiol 74, 41-68 (2012).
42. Katz, D. M., Dutschmann, M., Ramirez, J. M. & Hilaire, G. Breathing disorders in Rett syndrome: progressive neurochemical dysfunction in the respiratory network after birth. Respir Physiol Neurobiol 168, 101-8 (2009).
43. Oginsky, M. F., Cui, N., Zhong, W., Johnson, C. M. & Jiang, C. Alterations in the cholinergic system of brain stem neurons in a mouse model of Rett syndrome. Am J Physiol Cell Physiol 307, C508-20 (2014).
44. Grosser, E. et al. Oxidative burden and mitochondrial dysfunction in a mouse model of Rett syndrome. Neurobiol Dis 48, 102-14 (2012).
45. Neary, M. T. & Breckenridge, R. A. Hypoxia at the heart of sudden infant death syndrome? Pediatr Res 74, 375-9 (2013).
46. Zeevi-Levin, N. et al. Gap junctional remodeling by hypoxia in cultured neonatal rat ventricular myocytes. Cardiovasc Res 66, 64-73 (2005).
47. De Felice, C. et al. Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome. Neurobiol Dis 68, 66-77 (2014).
48. Feng, Y., Huang, W., Wani, M., Yu, X. & Ashraf, M. Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS One 9, e88685 (2014).
49. Kuwabara, Y. et al. Increased expression of HCN channels in the ventricular myocardium contributes to enhanced arrhythmicity in mouse failing hearts. J Am Heart Assoc 2, e000150 (2013).
50. Oba, T. et al. Cardiac-specific deletion of SOCS-3 prevents development of left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 59, 838-52 (2012).
51. Kawai, T. et al. Efficient cardiomyogenic differentiation of embryonic stem cell by fibroblast growth factor 2 and bone morphogenetic protein 2. Circ J 68, 691-702 (2004).
52. Takahashi, T. et al. Identification and isolation of embryonic stem cell-derived target cells by adenoviral conditional targeting. Mol Ther 14, 673-83 (2006).
53. Okabe, Y. et al. Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: a system for studying Rett syndrome. Brain Res 1360, 17-27 (2010).
54. Li, L. C. & Dahiya, R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 18, 1427-31 (2002).
55. El-Osta, A. & Wolffe, A. P. Analysis of chromatin-immunopurified MeCP2-associated fragments. Biochem Biophys Res Commun 289, 733-7 (2001).
56. Alvarez-Saavedra, M. et al. miRNA-132 orchestrates chromatin remodeling and translational control of the circadian clock. Hum Mol Genet 20, 731-51 (2011).